Fortrea Holdings (FTRE) Short term Debt (2023 - 2026)
Fortrea Holdings' (FTRE) quarterly Short term Debt came in at $17.1 million in Q2 2026, down 77.14% on a YoY basis from $74.8 million in Q2 2025, and up 56.88% quarter-over-quarter from $10.9 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Short term Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Short term Debt for 4 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt fell 77.14% year-over-year to $17.1 million; the trailing twelve-month figure through Jun 2026 stood at $17.1 million (down 77.14% YoY), and the FY2025 full-year result was $4.8 million, down 93.58% from the prior year.
- Short term Debt grew to $17.1 million in Q2 2026 per FTRE's latest filing, from $10.9 million in the prior quarter.
- Across five years, Short term Debt topped out at $163.8 million in Q1 2025 and bottomed at $4.8 million in Q4 2025.
- Historically, Short term Debt has averaged $50.4 million across 4 years, with a median of $26.1 million in 2023.
- The widest YoY moves for Short term Debt: up 197.82% in 2025, down 93.58% in 2025.
- Over 4 years, Short term Debt stood at $26.1 million in 2023, then soared by 186.59% to $74.8 million in 2024, then slumped by 93.58% to $4.8 million in 2025, then soared by 256.25% to $17.1 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $17.1 million, $10.9 million, and $4.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.10 Mn |
| Mar 31, 2026 | 10.90 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 74.50 Mn |
| Jun 30, 2025 | 74.80 Mn |
| Mar 31, 2025 | 163.80 Mn |
| Dec 31, 2024 | 74.80 Mn |
| Mar 31, 2024 | 55.00 Mn |
| Dec 31, 2023 | 26.10 Mn |
| Sep 30, 2023 | 26.10 Mn |
| Jun 30, 2023 | 26.10 Mn |